Microdosing: Taking Tiny Amounts of Psychedelic Drugs
Microdosing means taking very small amounts of psychedelic drugs. Users typically take about 1/10th to 1/20th of a normal dose. The goal is to potentially gain benefits without feeling high or experiencing hallucinations. This practice started in Silicon Valley, where some tech workers sought to enhance their cognitive performance. Now, people may use it for mood enhancement, creativity, and focus. However, the scientific evidence supporting these benefits is limited.
What Science Actually Shows
Scientists have conducted very few studies on microdosing. We know that regular doses of these drugs can affect brain chemicals called serotonin receptors. However, the effects of tiny doses are not well understood. A 2019 study involved participants who microdosed, and many reported feeling better and more focused. However, when researchers used placebo pills as controls, the perceived benefits diminished significantly. This suggests that many of the positive feelings may stem from the expectation of improvement rather than the effects of the drugs themselves. The brain changes resulting from tiny doses remain largely unexplored. Regular doses can lead to significant changes in communication between brain areas, while microdoses may not have the same impact.
What Users Say They Feel
Many users report several main benefits, with improved mood often at the top of the list. They describe feeling less anxious and sad, and report greater emotional stability. Creative individuals frequently mention discovering new ways to approach problems, and they often feel that routine tasks become more engaging. Enhanced focus and productivity are also commonly reported. However, it is important to consider that improvements in mood may be influenced by psychological factors. When individuals take something with the expectation that it will help, they may experience positive changes due to the placebo effect, which can be quite powerful in relation to mood and cognitive function.
Common Drugs and How People Take Them
Many individuals use magic mushrooms or LSD for microdosing. Mushroom doses typically range from 0.1 to 0.3 grams of dried mushrooms, while LSD doses generally fall between 10 to 20 micrograms. These amounts are not expected to induce hallucinations or significant alterations in perception. The Fadiman method suggests taking a dose every third day to prevent the body from developing a tolerance. The Stamets method involves taking doses for four days followed by three days off. Some users may also incorporate other supplements like niacin. Maintaining consistency is important for those looking to assess whether microdosing is effective. Altering doses, drugs, or timing can complicate the ability to determine what might be contributing to any observed effects.
Legal Problems Are Very Real
These drugs are illegal in many places. In the US, magic mushrooms and LSD are classified as Schedule I substances, meaning they are treated similarly to heroin. Being caught with these substances can lead to legal consequences, including jail time, fines, and a criminal record. Oregon has made some changes, allowing supervised mushroom therapy and de-prioritizing arrests for personal use. Some cities have also made enforcement of laws against these drugs less of a priority. However, federal law still applies nationwide, and federal agents can enforce the law regardless of local policies. The legal risks are immediate and significant, while the benefits remain largely unverified.
Health Risks You Need to Know
Even tiny doses can lead to adverse effects for some individuals. A subset of users may experience increased anxiety, mood swings, or sleep disturbances. Those with a family history of mental illness may face heightened risks. Street drugs pose significant safety concerns, as the actual contents can be unpredictable. There is a possibility of receiving substances that are different from what was intended, which may contain harmful chemicals or be much stronger than anticipated. Certain prescription medications may not interact well with psychedelics. Antidepressants, for instance, can lead to negative reactions. Discontinuing regular medications to try microdosing could also pose risks.
Why We Need Better Research
Current studies have notable limitations. Many rely on participants who already believe in the efficacy of microdosing, which can introduce bias into the results. The illegal status of these substances complicates the ability to conduct rigorous research. Testing these drugs against placebos can be challenging, as individuals often discern between the real substance and a sugar pill, which undermines the scientific process. A few universities are attempting to conduct more robust studies, but results may take time to emerge. At present, there is a lack of clarity regarding safety and potential benefits.
The Bottom Line on Risk vs Reward
Microdosing exists in a complex space between hopeful anecdotes and a lack of solid evidence. The legal and health risks are real and can manifest quickly, while the benefits remain largely unproven and may be influenced by psychological factors. Individuals considering this practice may be engaging in self-experimentation with illegal substances. Local law enforcement may overlook these activities today, but policies can change. Federal agents retain the authority to prosecute individuals anywhere in the US. If you are experiencing depression or anxiety, it is advisable to consult with a healthcare professional first. There are legal treatments available that have been effective for many individuals. Some regions are beginning to offer legal psychedelic therapy programs, which may provide safer alternatives to illicit substances. The appeal of microdosing is understandable, as traditional treatments do not work for everyone. However, the current risks may outweigh the uncertain benefits for many individuals. Better options may emerge in the future, but they are not available at this time.